Sialidosis type I
Other Names for this Disease
- Cherry red spot myoclonus syndrome
- Myoclonus cherry red spot syndrome
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
There is no specific treatment for sialidosis. Management should be multidisciplinary and directed at supportive care and symptomatic relief. Overall health maintenance should be a priority, with seizure control as necessary. Myoclonic seizures often respond poorly to treatment with anticonvulsant medications.
Last updated: 8/13/2015
- Roth KS. Sialidosis (Mucolipidosis I): Treatment & Medication. Medscape Reference. December 13, 2013; http://emedicine.medscape.com/article/948704-treatment. Accessed 8/13/2015.
- Maire I, Froissart R. Sialidosis type 1. Orphanet. 2007; http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=812. Accessed 8/13/2015.
- The Research Portfolio Online Reporting Tool (RePORT) provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research. Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the "Text Search" box. Then click "Submit Query".